• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

COVID-19大流行期间热性惊厥的流行病学:一项加拿大免疫监测项目-主动(IMPACT)研究。

EPIDEMIOLOGY OF FEBRILE SEIZURES DURING THE COVID-19 PANDEMIC: A CANADIAN IMMUNIZATION MONITORING PROGRAM-ACTIVE (IMPACT) STUDY.

作者信息

Top Karina A, Shulha Hennady P, Hassan Fahima, Sauvé Laura, Jadavji Taj, Purewal Rupeena, Constantinescu Cora, Sadarangani Manish, Halperin Scott A, Morris Shaun K, Bettinger Julie A

机构信息

From the Canadian Center for Vaccinology, IWK Health and Dalhousie University, Halifax, Nova Scotia.

Department of Community Health & Epidemiology, Dalhousie University, Halifax, Nova Scotia.

出版信息

Pediatr Infect Dis J. 2025 Feb 18;44(6):e230-3. doi: 10.1097/INF.0000000000004759.

DOI:10.1097/INF.0000000000004759
PMID:39970321
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12058355/
Abstract

Active surveillance for febrile seizures was conducted at 12 Canadian pediatric centers (August 2021-December 2022). Of 3367 cases, 649 (19%) were hospitalized, 156/3367 (5%) had laboratory-confirmed acute SARS-CoV-2 infection, 363 (11%) had non-SARS-CoV-2 infection and 107 (3%) occurred as adverse events following immunization (vaccinated within 15 days before presentation). Febrile seizures were more frequently associated with infection than vaccination.

摘要

加拿大的12个儿科中心开展了对热性惊厥的主动监测(2021年8月至2022年12月)。在3367例病例中,649例(19%)住院治疗,3367例中有156例(5%)经实验室确诊为急性SARS-CoV-2感染,363例(11%)为非SARS-CoV-2感染,107例(3%)为免疫接种后的不良事件(就诊前15天内接种过疫苗)。热性惊厥与感染的相关性高于与疫苗接种的相关性。

相似文献

1
EPIDEMIOLOGY OF FEBRILE SEIZURES DURING THE COVID-19 PANDEMIC: A CANADIAN IMMUNIZATION MONITORING PROGRAM-ACTIVE (IMPACT) STUDY.COVID-19大流行期间热性惊厥的流行病学:一项加拿大免疫监测项目-主动(IMPACT)研究。
Pediatr Infect Dis J. 2025 Feb 18;44(6):e230-3. doi: 10.1097/INF.0000000000004759.
2
COVID-19 Vaccination and Odds of Post-COVID-19 Condition Symptoms in Children Aged 5 to 17 Years.5至17岁儿童的新冠病毒疫苗接种与新冠后症状出现几率
JAMA Netw Open. 2025 Feb 3;8(2):e2459672. doi: 10.1001/jamanetworkopen.2024.59672.
3
COVID-19 Vaccine Effectiveness and Digital Pandemic Surveillance in Germany (eCOV Study): Web Application-Based Prospective Observational Cohort Study.德国 COVID-19 疫苗有效性和数字大流行监测(eCOV 研究):基于网络应用的前瞻性观察队列研究。
J Med Internet Res. 2024 Jun 4;26:e47070. doi: 10.2196/47070.
4
COVID-19 Vaccine Effectiveness in Autumn and Winter 2022 to 2023 Among Older Europeans.2022 年至 2023 年秋冬期间,老年欧洲人群中的 COVID-19 疫苗有效性。
JAMA Netw Open. 2024 Jul 1;7(7):e2419258. doi: 10.1001/jamanetworkopen.2024.19258.
5
Characteristics of children with influenza admitted to a pediatric hospital in Greece during the 2022/2023 and 2023/2024 seasons.2022/2023年和2023/2024年流感季期间入住希腊一家儿科医院的流感患儿特征。
Eur J Pediatr. 2025 Aug 5;184(8):530. doi: 10.1007/s00431-025-06338-8.
6
Rotavirus trends and distribution of genotypes before and during COVID-19 pandemic era: Bangladesh, 2017-2021.2017 - 2021年孟加拉国新冠疫情大流行之前及期间轮状病毒的流行趋势和基因型分布
J Med Virol. 2024 May;96(5):e29681. doi: 10.1002/jmv.29681.
7
Risk of myocarditis and pericarditis after a COVID-19 mRNA vaccine booster and after COVID-19 in those with and without prior SARS-CoV-2 infection: A self-controlled case series analysis in England.在有和没有先前 SARS-CoV-2 感染的人群中,COVID-19 mRNA 疫苗加强针接种后和 COVID-19 后心肌炎和心包炎的风险:在英国的一项自身对照病例系列分析。
PLoS Med. 2023 Jun 7;20(6):e1004245. doi: 10.1371/journal.pmed.1004245. eCollection 2023 Jun.
8
Safety and immunogenicity of a modified mRNA-lipid nanoparticle vaccine candidate against COVID-19: Results from a phase 1, dose-escalation study.针对 COVID-19 的一种改良信使核糖核酸-脂质纳米颗粒候选疫苗的安全性和免疫原性:一项 1 期、剂量递增研究的结果。
Hum Vaccin Immunother. 2024 Dec 31;20(1):2408863. doi: 10.1080/21645515.2024.2408863. Epub 2024 Oct 18.
9
Risk factors for infection with SARS-CoV-2 in a cohort of Canadian healthcare workers: 2020-2023.2020 - 2023年加拿大医护人员队列中感染新型冠状病毒2的风险因素
Epidemiol Infect. 2025 Jun 23;153:e72. doi: 10.1017/S0950268825100101.
10
COVID-19 Vaccines2019冠状病毒病疫苗

本文引用的文献

1
Neurological Manifestations of Acute SARS-CoV-2 Infection in Pediatric Patients: A 3-Year Study on Differences between Pandemic Waves.急性 SARS-CoV-2 感染在儿科患者中的神经表现:关于大流行浪潮之间差异的 3 年研究。
Viruses. 2024 Jun 17;16(6):967. doi: 10.3390/v16060967.
2
The evolution of SARS-CoV-2 seroprevalence in Canada: a time-series study, 2020-2023.SARS-CoV-2 血清流行率在加拿大的演变:2020-2023 年的时间序列研究。
CMAJ. 2023 Aug 14;195(31):E1030-E1037. doi: 10.1503/cmaj.230249.
3
The Association Between COVID-19 and Febrile Seizure: A Retrospective Case-Control Study.新型冠状病毒肺炎与热性惊厥的相关性:一项回顾性病例对照研究。
Pediatr Emerg Care. 2023 May 1;39(5):360-363. doi: 10.1097/PEC.0000000000002935. Epub 2023 Apr 21.
4
COVID-19 mRNA Vaccine Safety Among Children Aged 6 Months-5 Years - United States, June 18, 2022-August 21, 2022.2022年6月18日至2022年8月21日美国6个月至5岁儿童中新冠病毒mRNA疫苗的安全性
MMWR Morb Mortal Wkly Rep. 2022 Sep 2;71(35):1115-1120. doi: 10.15585/mmwr.mm7135a3.
5
Active surveillance of acute paediatric hospitalisations demonstrates the impact of vaccination programmes and informs vaccine policy in Canada and Australia.对急性儿科住院病例的主动监测,展示了疫苗接种计划在加拿大和澳大利亚的影响,并为疫苗政策提供了信息。
Euro Surveill. 2020 Jun;25(25). doi: 10.2807/1560-7917.ES.2020.25.25.1900562.
6
Postvaccination Febrile Seizure Severity and Outcome.疫苗接种后热性惊厥严重程度和结局。
Pediatrics. 2019 May;143(5). doi: 10.1542/peds.2018-2120.
7
Risk of febrile seizures after first dose of measles-mumps-rubella-varicella vaccine: a population-based cohort study.首剂麻疹-腮腺炎-风疹-水痘疫苗后热性惊厥的风险:一项基于人群的队列研究。
CMAJ. 2014 Aug 5;186(11):824-9. doi: 10.1503/cmaj.140078. Epub 2014 Jun 9.
8
Generalized convulsive seizure as an adverse event following immunization: case definition and guidelines for data collection, analysis, and presentation.全身性惊厥发作作为免疫接种后的不良事件:病例定义及数据收集、分析和报告指南。
Vaccine. 2004 Jan 26;22(5-6):557-62. doi: 10.1016/j.vaccine.2003.09.008.